Sclerosing encapsulating peritonitis (SEP) as a delayed complication of continuous hyperthermic peritoneal perfusion (CHPP): Report of a case

Surgery Today

Volumn 33, Issue 3, 2003, Pages 232-236

  Aihara, Hiroyuki ^a   Maruoka, Hidenori ^a   Kiyozaki, Hirokazu ^a   Konishi, Fumio ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Complication; Continuous hyperthermic peritoneal perfusion; Gastric cancer; Sclerosing encapsulating peritonitis

Indexed keywords

ADULT; ARTICLE; ASCENDING COLON; CASE REPORT; COLON ANASTOMOSIS; CONTINUOUS HYPERTHERMIC PERITONEAL PERFUSION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; ILEUS; INTESTINE OBSTRUCTION; LABORATORY TEST; LAPAROTOMY; PERITONEUM; PERITONITIS; QUALITY OF LIFE; RADIOLOGY; RECURRENT DISEASE; SCLEROSING ENCAPSULATING PERITONITIS; SEROSA; SMALL INTESTINE; STOMACH CANCER; SURGICAL TECHNIQUE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CISPLATIN; FEMALE; FLUOROURACIL; HUMANS; HYPERTHERMIA, INDUCED; INTESTINAL OBSTRUCTION; METHOTREXATE; MIDDLE AGED; MITOMYCIN; PERITONITIS; SCLEROSIS; STOMACH NEOPLASMS; TIME FACTORS;

EID: 0037234741     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005950300052     Document Type: Article

References (15)

1. Iitsuka Y, Kaneshima S, Tanida O, Takeuchi T, Koga S. Intraperitoneal free cancer cells and their viability in gastric cancer. Cancer 1979;44:1476-80.
2. Hamazoe R, Maeta M, Kaibara N. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study. Cancer 1994;73;2048-52.
3. Kiyozaki H, Kobayashi E, Suganuma H, Hata M, Adachi K, Miyata M, et al. Studies on immunological changes after continuous hyperthermic peritoneal perfusion (CHPP) for gastric cancer. In: Proceedings of the 2nd International Gastric Cancer Congress, Munich (Germany); 1997. p. 1413-5.
4. Fujimura T, Yonemura Y, Fushida S, Urade M, Takegawa S, Kamata T, et al. Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation. Cancer 1990;65:65-71.
5. Koga S, Hamazoe R, Maeta M, Shimizu N, Murakami A, Wakatsuki T. Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer 1988;61:232-7.
6. Hamazoe R, Koga S, Maeta M, Yamane T, Oda M. The effect of continuous hyperthermic peritoneal perfusion on prophylaxis of postoperative peritoneal metastasis in gastric cancer surgery. In: Overgaard J, editor. Hyperthermic oncology 1984, vol. 1, Summary papers. London: Taylor & Francis; 1984. p. 799-802.
7. Nomoto Y, Kawaguchi Y, Kubo H, Hirano H, Sakai S, Kurokawa K. Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese sclerosing encapsulating peritonitis study group. Am J Kidney Dis 1996;28:420-7.
8. Slingeneyer A, Mion C, Mourad G, Canud B, Faller B, Beraud JJ. Progressive sclerosing peritonitis: a late and severe complication of maintenance peritoneal dialysis. ASAIO Trans 1983;29:633-8.
9. Marshall AJ, Baddeley H, Barritt DW, Davies JD, Lee RE, Low-Beer TS, et al. Practolol peritonitis. Q J Med 1977;46:135-49.
10. Nielsen BV, Pedersen KG. Sclerosing peritonitis associated with atenolol. Br Med J 1985;290:518.
11. Clark CV, Terris R. Sclerosing peritonitis associated with metoprolol. Lancet 1983;1:937.
12. Celicout B, Levard H, Hay J, Msika S, Fingerhut, A, Pelissier E. Sclerosing encapsulating peritonitis: early and late results of surgical treatment in 32 cases. Dig Surg 1998;15:697-702.
13. Shido A, Ohmura S, Yamamoto K, Kobayashi T, Fujimura T, Yonemura Y. Does hyperthermia induce peritoneal, damage in continuous hyperthermic peritoneal perfusion? World J Surg 2000;24:507-11.
14. Arizono K, Matsuoka K, Miyamoto T, Hayano K, Fukui H, Kiyohara H, et al. Three successfully treated surgical cases of sclerosing encapsulating peritonitis. Tosekikai-shi 1999;32:1259-64.
15. Atiq O, Kelsen D, Shiu M, Saltz L, Tong W, Niedzwiecki D, et al. Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer. J Clin Oncol 1993;11:425-33.